Artwork
iconShare
 
Manage episode 400077233 series 2396963
Content provided by The Long Run with Luke Timmerman and Timmerman Report. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Long Run with Luke Timmerman and Timmerman Report or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.
  continue reading

185 episodes